Peg-interferon plus nucleotide ogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
de Niet A, Jansen L, Stelma F, Willemse , Kuiken SD, Weijer S, van Nieuwkerk CMJ, Zaaijer HL, Molenkamp R, Takkenberg RB, Koot M, Verheij J, Beuers U, Reesink HW.
Lancet Gastroenterol Hepatol. 2017 May 15. pii: S2468-1253(17)30083-3. doi: 10.1016/S2468-1253(17)30083-3. [Epub ahead of print]